Pharma · Private company
Takeda Pharmaceuticals North America, Inc.
Track this companyFree. Adds Takeda Pharmaceuticals North America, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- SAFE Study: Safety of aPCC Following Emicizumab ProphylaxisPHASE3 · WITHDRAWN · started Sep 1, 2026ClinicalTrials.gov NCT04563520 · fetched Nov 12, 2026
- ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening ProgramENROLLING_BY_INVITATION · started May 10, 2021ClinicalTrials.gov NCT05368038 · fetched Nov 12, 2026
- Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory MyelomaPHASE2 · TERMINATED · started Feb 14, 2020ClinicalTrials.gov NCT04119336 · fetched Nov 12, 2026
- Pathophysiology of Uric Acid NephrolithiasisNA · COMPLETED · started Jan 15, 2010ClinicalTrials.gov NCT00904046 · fetched Nov 12, 2026
- Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy PreparationPHASE4 · COMPLETED · started Mar 1, 2008ClinicalTrials.gov NCT00645801 · fetched Nov 12, 2026
- Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging StudyPHASE4 · COMPLETEDClinicalTrials.gov NCT01161394 · fetched Nov 12, 2026